NIHON CHOUZAI Co.,Ltd. (TYO:3341)
1,454.00
+32.00 (2.25%)
Mar 14, 2025, 3:30 PM JST
NIHON CHOUZAI Revenue
NIHON CHOUZAI had revenue of 94.22B JPY in the quarter ending December 31, 2024, with 7.30% growth. This brings the company's revenue in the last twelve months to 355.98B, up 6.39% year-over-year. In the fiscal year ending March 31, 2024, NIHON CHOUZAI had annual revenue of 340.31B with 8.61% growth.
Revenue (ttm)
355.98B
Revenue Growth
+6.39%
P/S Ratio
0.12
Revenue / Employee
60.71M
Employees
5,864
Market Cap
43.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 340.31B | 26.99B | 8.61% |
Mar 31, 2023 | 313.32B | 13.93B | 4.65% |
Mar 31, 2022 | 299.39B | 20.44B | 7.33% |
Mar 31, 2021 | 278.95B | 10.43B | 3.88% |
Mar 31, 2020 | 268.52B | 22.83B | 9.29% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |